Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (301-310 of 355) with videos related to

Pageof 36
Sort By:
Journal for Immunotherapy of Cancer|November 19, 2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatmentAlice Newey, Beatrice Griffiths, Justine Michaux, et al.
Nature Immunology|April 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8<sup>+</sup> T cellsJesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Cancer Cell|April 25, 2020
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin LymphomaElie Dheilly, Elena Battistello, Natalya Katanayeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedsideCheryl Lai-Lai Chiang, Lana E Kandalaft, Janos Tanyi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Nature Immunology|October 6, 2020
Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustionYi-Ru Yu, Hana Imrichova, Haiping Wang, et al.
Cancer Research|December 17, 2008
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancerNuo Yang, Sippy Kaur, Stefano Volinia, et al.
Nature Medicine|August 24, 2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalTyler J Curiel, George Coukos, Linhua Zou, et al.
Cytotherapy|October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environmentPhilippe O Gannon, Alexandre Harari, Aymeric Auger, et al.
Pageof 36

Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
Journal for Immunotherapy of Cancer|November 19, 2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatmentAlice Newey, Beatrice Griffiths, Justine Michaux, et al.
Nature Immunology|April 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8<sup>+</sup> T cellsJesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Cancer Cell|April 25, 2020
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin LymphomaElie Dheilly, Elena Battistello, Natalya Katanayeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedsideCheryl Lai-Lai Chiang, Lana E Kandalaft, Janos Tanyi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Nature Immunology|October 6, 2020
Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustionYi-Ru Yu, Hana Imrichova, Haiping Wang, et al.
Cancer Research|December 17, 2008
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancerNuo Yang, Sippy Kaur, Stefano Volinia, et al.
Nature Medicine|August 24, 2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalTyler J Curiel, George Coukos, Linhua Zou, et al.
Cytotherapy|October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environmentPhilippe O Gannon, Alexandre Harari, Aymeric Auger, et al.
Pageof 36